logo for PROF

PROF • NASDAQ

Profound Medical Corp.

$6.91

+ Add to Watchlist

Stock Details

Market Cap 251,092,816
Day Change 1.23 (21.65%)
Volume 2,954,277
Avg Volume 104,113
Price Range 4.8-8.95

Overview

Country CA
Sector Healthcare
Industry Medical - Devices
Exchange NASDAQ

Company Profile

Profound Medical Corp., through its subsidiaries, is a commercial-stage medical technology firm specializing in the development of magnetic resonance (MR)-guided ablation solutions. These innovative procedures are designed to treat conditions such as prostate disease and uterine fibroids, as well as providing palliative pain relief. The company markets its solutions across Canada, Germany, the United States, and Finland. Its flagship product, the TULSA-PRO system, is specifically designed for use with magnetic resonance imaging (MRI) scanners within hospital settings and other treatment centers. Additionally, Profound Medical offers Sonalleve, a therapeutic platform that addresses uterine fibroids – including through non-invasive methods – and provides palliative relief for pain linked to bone metastases. The company's primary operations are headquartered in Mississauga, Canada.

Financial Overview

52 Week High 12.4
52 Week High Date 2026-01-13
52 Week Low 6.52
52 Week Low Date 2026-03-09
10D Avg Trading Vol 0.00731
YTD Price Return Daily -19.5915
MTD Price Return Daily 3.8369

Cash Flow

TTM/Share -1.81517
Annual/Share -1.0594
Quarterly/Share -0.9948

Price-to-Earnings

Annual Ratio 12.5249
Quarterly Ratio 6.4593
TTM

Revenue

3Y Growth 34.06
5Y Growth 17.12
Annual/Share 12.3
TTM/Share 0.5251
5Y Share Growth 4.75

Earnings Per Share

Annual -1.4081
3Y Growth
5Y Growth
Quarterly YOY Growth

Price-to-Book

Ratio 4.4637
Annual Ratio 3.1651
TTM 4.8351